BR9611571B1 - composiÇço farmacÊutica estÁvel, kit para administraÇço de ngf e produto medicinal. - Google Patents

composiÇço farmacÊutica estÁvel, kit para administraÇço de ngf e produto medicinal.

Info

Publication number: BR9611571B1
Authority: BR; Brazil
Prior art keywords: pharmaceutical composition; medicinal product; stable pharmaceutical; ngf; administration kit
Prior art date: 1995-11-07

Application number

BRPI9611571-8A

Other languages

English (en)

Other versions

BR9611571A (pt

Inventor

Young Linda R De

Xanthe M Lam

Tue Nguyen

Michael F Powell

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-11-07

Filing date

1996-10-21

Publication date

2009-01-13

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24214304&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9611571(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1996-10-21 Application filed filed Critical

1999-03-30 Publication of BR9611571A publication Critical patent/BR9611571A/pt

2009-01-13 Publication of BR9611571B1 publication Critical patent/BR9611571B1/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Zoology (AREA)
Biomedical Technology (AREA)
Psychology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pretreatment Of Seeds And Plants (AREA)
Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

BRPI9611571-8A 1995-11-07 1996-10-21 composiÇço farmacÊutica estÁvel, kit para administraÇço de ngf e produto medicinal. BR9611571B1 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US55468595A	1995-11-07	1995-11-07
PCT/US1996/016881 WO1997017087A1 (en)	1995-11-07	1996-10-21	Stabilizing formulation for ngf

Publications (2)

Publication Number	Publication Date
BR9611571A BR9611571A (pt)	1999-03-30
BR9611571B1 true BR9611571B1 (pt)	2009-01-13

Family

ID=24214304

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI9611571-8A BR9611571B1 (pt)	1995-11-07	1996-10-21	composiÇço farmacÊutica estÁvel, kit para administraÇço de ngf e produto medicinal.

Country Status (18)

Country	Link
EP (1)	EP0862452B1 (pt)
JP (1)	JP4057058B2 (pt)
KR (1)	KR100497087B1 (pt)
CN (1)	CN1126567C (pt)
AT (1)	ATE255903T1 (pt)
AU (1)	AU721112B2 (pt)
BR (1)	BR9611571B1 (pt)
CA (1)	CA2234231C (pt)
DE (1)	DE69631063T2 (pt)
DK (1)	DK0862452T3 (pt)
ES (1)	ES2211991T3 (pt)
HK (1)	HK1015261A1 (pt)
IL (1)	IL124004A (pt)
MX (1)	MX9803342A (pt)
PT (1)	PT862452E (pt)
TR (1)	TR199800811T2 (pt)
WO (1)	WO1997017087A1 (pt)
ZA (1)	ZA969290B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1998046254A1 (en) *	1997-04-11	1998-10-22	Roche Diagnostics Gmbh	Ngf for the prevention of demyelination in the nervous system
US6171586B1 (en)	1997-06-13	2001-01-09	Genentech, Inc.	Antibody formulation
US6663899B2 (en)	1997-06-13	2003-12-16	Genentech, Inc.	Controlled release microencapsulated NGF formulation
US6991790B1 (en)	1997-06-13	2006-01-31	Genentech, Inc.	Antibody formulation
US6113947A (en) *	1997-06-13	2000-09-05	Genentech, Inc.	Controlled release microencapsulated NGF formulation
US7282482B2 (en)	1998-04-08	2007-10-16	The Regents Of The University Of California	NGF for the prevention of demyelination in the nervous system
WO2000004913A1 (en) *	1998-07-23	2000-02-03	Eli Lilly And Company	Fsh and fsh variant formulations, products and methods
US20030166525A1 (en)	1998-07-23	2003-09-04	Hoffmann James Arthur	FSH Formulation
WO2003000257A1 (fr) *	2001-06-26	2003-01-03	Takeda Chemical Industries, Ltd.	Promoteur de production/secretion de la superfamille des tgf-$g(b)
DE10219545A1 (de) *	2002-04-26	2003-11-06	Lang Florian	Regulation der Apoptose
SI1610822T2 (sl)	2003-04-02	2018-12-31	Ares Trading S.A.	Tekoče farmacevtske formulacije fsh in lh, skupaj z neionsko površinsko aktivno snovjo
AR044302A1 (es) *	2003-05-13	2005-09-07	Ares Trading Sa	Formulaciones con proteinas liquidas estabilizadas en recipientes farmaceuticos
CN1318087C (zh) *	2003-06-06	2007-05-30	北京三诺佳邑生物技术有限责任公司	去白蛋白神经生长因子制剂
JP4871124B2 (ja)	2003-06-20	2012-02-08	アレストレーディングソシエテアノニム	凍結乾燥ｆｓｈ／ｌｈ製剤
DE10333317A1 (de) *	2003-07-22	2005-02-17	Biotecon Therapeutics Gmbh	Formulierung für Proteinarzneimittel ohne Zusatz von humanem Serumalbumin (HSA)
CN108348579B (zh)	2015-04-21	2021-04-27	舒泰神（北京）生物制药股份有限公司	神经生长因子组合物及注射粉剂
JP6533834B2 (ja) *	2016-01-04	2019-06-19	グレープキングバイオエルティーディー．ＧｒａｐｅＫｉｎｇＢｉｏＬｔｄ．	聴覚低下を予防するための活性物質、活性物質を含む組成物及びその調製方法
CN114252519B (zh) *	2020-09-23	2023-11-24	舒泰神（北京）生物制药股份有限公司	一种测定神经生长因子纯度的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL109350A (en) *	1993-05-12	2001-01-28	Genentech Inc	Stable liquid compositions of gamma interferon
US6277828B1 (en) *	1993-08-20	2001-08-21	Syntex (U.S.A.) Inc.	Pharmaceutical formulations of nerve growth factor

1996
- 1996-10-21 CN CN96198066A patent/CN1126567C/zh not_active Expired - Lifetime
- 1996-10-21 TR TR1998/00811T patent/TR199800811T2/xx unknown
- 1996-10-21 BR BRPI9611571-8A patent/BR9611571B1/pt not_active IP Right Cessation
- 1996-10-21 JP JP51819197A patent/JP4057058B2/ja not_active Expired - Lifetime
- 1996-10-21 AT AT96937710T patent/ATE255903T1/de active
- 1996-10-21 WO PCT/US1996/016881 patent/WO1997017087A1/en active IP Right Grant
- 1996-10-21 DE DE69631063T patent/DE69631063T2/de not_active Expired - Lifetime
- 1996-10-21 CA CA002234231A patent/CA2234231C/en not_active Expired - Lifetime
- 1996-10-21 DK DK96937710T patent/DK0862452T3/da active
- 1996-10-21 ES ES96937710T patent/ES2211991T3/es not_active Expired - Lifetime
- 1996-10-21 PT PT96937710T patent/PT862452E/pt unknown
- 1996-10-21 AU AU75186/96A patent/AU721112B2/en not_active Expired
- 1996-10-21 EP EP96937710A patent/EP0862452B1/en not_active Expired - Lifetime
- 1996-10-21 IL IL12400496A patent/IL124004A/xx not_active IP Right Cessation
- 1996-10-21 KR KR10-1998-0703357A patent/KR100497087B1/ko not_active Expired - Lifetime
- 1996-11-05 ZA ZA9609290A patent/ZA969290B/xx unknown
1998
- 1998-04-28 MX MX9803342A patent/MX9803342A/es active IP Right Grant
1999
- 1999-01-16 HK HK99100226A patent/HK1015261A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
ATE255903T1 (de)	2003-12-15
CA2234231A1 (en)	1997-05-15
BR9611571A (pt)	1999-03-30
ZA969290B (en)	1998-05-05
IL124004A (en)	2003-10-31
KR100497087B1 (ko)	2005-09-09
JP2002502358A (ja)	2002-01-22
PT862452E (pt)	2004-04-30
CN1126567C (zh)	2003-11-05
MX9803342A (es)	1998-09-30
TR199800811T2 (xx)	1998-07-21
EP0862452A1 (en)	1998-09-09
CN1201394A (zh)	1998-12-09
KR19990067350A (ko)	1999-08-16
ES2211991T3 (es)	2004-07-16
JP4057058B2 (ja)	2008-03-05
AU721112B2 (en)	2000-06-22
EP0862452B1 (en)	2003-12-10
CA2234231C (en)	2009-04-14
HK1015261A1 (en)	1999-10-15
DE69631063T2 (de)	2004-09-30
DE69631063D1 (de)	2004-01-22
DK0862452T3 (da)	2004-04-05
WO1997017087A1 (en)	1997-05-15
AU7518696A (en)	1997-05-29

Publication	Publication Date	Title
BR9611571B1 (pt)	2009-01-13	composiÇço farmacÊutica estÁvel, kit para administraÇço de ngf e produto medicinal.
AU6628496A (en)	1996-12-30	Polyether block copolymer micellar compositions for targeting biological agents
FI971776A0 (fi)	1997-04-25	Yhdisteet ja koostumukset aktiivisten aineiden antamiseksi
CA2068324A1 (en)	1991-05-14	Metal-peptide compositions and methods for stimulating hair growth
ATE213164T1 (de)	2002-02-15	Verwendung von nona- und dekapeptiden zur herstellung eines arzneimittels zur bekämpfung von aids
DE69620877D1 (de)	2002-05-29	Arzneimittelformulierungen für il-12
HRP20020880B1 (en)	2006-04-30	New pharmaceutical composition
MY115662A (en)	2003-08-30	Novel compounds with analgesic effect
MX9709094A (es)	1998-03-31	Formulaciones farmaceuticas de derivados muy lipofilos de la comptotecina.
BR9407278A (pt)	1996-10-01	Formulações farmacêuticas do fator de crescimento dos nervos
MY111260A (en)	1999-10-30	Pharmaceutical composition for the treatment of nicotine dependence
MY115211A (en)	2003-04-30	Novel amino acid derivatives, their preparation and use
ES2160821T3 (es)	2001-11-16	Uso de una composicion que comprende amoxicilina y acido clavulanico para la produccion de un medicamento para el tratamiento de infecciones bacterianas en pacientes pediatricos.
UA35611C2 (uk)	2001-04-16	Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри
ES2174054T3 (es)	2002-11-01	Composiciones farmaceuticas acuosas liquidas que comprenden alginato sodico y bicarbonato potasico.
NO306762B1 (no)	1999-12-20	Anvendelse av lanolinderivater sammen med polyetylenglykoletere, blanding derav og transdermalt terapeutisk system
ES8707488A1 (es)	1985-12-01	Un metodo para preparar maleato de 2-terc-butilamino-3'-cloropropiofenona
PL318130A1 (en)	1997-05-12	Terpenod derivatives (of sarcodictyine)as antineoplastic agents
DE3560313D1 (en)	1987-08-13	Improvements in or relating to anticonvulsant agents
TW374085B (en)	1999-11-11	Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use
ES8704903A1 (es)	1987-04-16	Un metodo para preparar 6-cloro-2-metil-1h-2,3,4,5-tetrahidro-3-benzazepen-n-oxido.
AU7533394A (en)	1995-02-28	Antiacid pharmaceutical composition in the form of a suspension based on sucralphate gel
UA5743C2 (uk)	1994-12-29	Препарат тканинних біологічно активних речовин, який має регенаторну дію, та спосіб його одержання
MX9708385A (es)	1998-01-31	Derivados novedosos de tetraciclina, composiciones que los contienen, y el uso de las mismas.
MX9804797A (es)	1998-10-31	Nuevos compuestos con efecto analgesico.

Legal Events

Date	Code	Title	Description
2003-01-07	EG	Technical examination (opinion): publication of technical examination (opinion)
2005-01-04	B09B	Patent application refused [chapter 9.2 patent gazette]
2005-03-29	B12B	Appeal against refusal [chapter 12.2 patent gazette]
2007-08-14	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2007-09-18	B09Y	Publication of grant cancelled [chapter 9.1.2 patent gazette]
2009-02-25	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 25/02/2009, OBSERVADAS AS CONDICOES LEGAIS.
2013-10-29	B22O	Other matters related to patents and certificates of addition of invention: legal action concerning patent	Free format text: INPI-52400.68489/2013 ORIGEM: JUIZO DA 001A VARA FEDERAL DE SAO PAULO PROCESSO NO 0017575-93.2013.4.03.6100 ACAO DE NULIDADE DE PATENTE AUTOR: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI REU: GENENTECH, INC., CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA, PELE NOVA BIOTECNOLOGIA S/A E UNILEVER N.V.
2013-12-17	B21B	Extinction acc. art. 78, item ii - on waiver by the patentee, without prejudice to the rights of third parties	Free format text: SOLICITADA ATRAVES DA PETICAO 18130035057 (SP), DE 21/10/2013